Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen

• Published in: Psychopharmacology 2015-05, Vol.232 (10), p.1831-1841
• Main Authors: Maccioni, Paola, Vargiolu, Daniela, Thomas, Andrew W., Malherbe, Pari, Mugnaini, Claudia, Corelli, Federico, Leite-Morris, Kimberly A., Gessa, Gian Luigi, Colombo, Giancarlo
• Format: Article
• Language: English
• Subjects: Alcohol Drinking - drug therapy; Alcohol Drinking - genetics; Alcohol Drinking - psychology; Allosteric Regulation - drug effects; Allosteric Regulation - physiology; Animals; Baclofen - administration & dosage; Benzofurans - administration & dosage; Biomedical and Life Sciences; Biomedicine; Cyclopentanes - administration & dosage; Drug Synergism; Drug Tolerance - physiology; Ethanol - administration & dosage; Ethanol - antagonists & inhibitors; Male; Neurosciences; Original Investigation; Pharmacology/Toxicology; Psychiatry; Pyrimidines - administration & dosage; Rats; Receptors, GABA-B - physiology; Self Administration
• ISSN: 0033-3158; 1432-2072
• DOI: 10.1007/s00213-014-3815-8

Rationale Treatment with positive allosteric modulators (PAMs) of the GABA B receptor (GABA B PAMs) inhibits several alcohol-motivated behaviors in rodents, including operant, oral alcohol self-administration. Objectives The present study assessed the effects of (a) repeated administration of the GABA B PAMs, GS39783, and rac -BHFF and (b) a combination of an ineffective dose of either GS39783, or rac -BHFF, and an ineffective dose of the prototypic GABA B receptor agonist, baclofen, on operant, oral alcohol self-administration. Methods Studies were conducted using selectively bred Sardinian alcohol-preferring (sP) rats exposed to a standard procedure of fixed ratio (FR) 4 (FR4) schedule of reinforcement for 15 % ( v / v ) alcohol. Results Repeated treatment with GS39783 (50 mg/kg, i.g.) or rac -BHFF (50 mg/kg, i.g.) produced an initial 40 % reduction in number of lever responses for alcohol and amount of self-administered alcohol that was maintained unaltered throughout the 10-day period of the GS39783 treatment and increased throughout the 5-day period of the rac -BHFF treatment. Combination of per se ineffective doses of GS39783 (5 mg/kg, i.g.), or rac -BHFF (5 mg/kg, i.g.), and baclofen (1 mg/kg, i.p.) reduced, by 35–45 %, both number of lever responses for alcohol and amount of self-administered alcohol. Conclusions GS39783 and rac -BHFF (a) reduced alcohol reinforcing properties when given repeatedly, with no development of tolerance, and (b) potentiated baclofen effect. Both sets of data possess translational interest, as they suggest potential effectiveness of GABA B PAMs under chronic treatment and selective potentiation of baclofen effect.